Elias AD - Search Results

1

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

Moore HC, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S; Southwest Oncology Group/Intergroup Study 9623. Moore HC, et al. Among authors: elias ad. J Clin Oncol. 2007 May 1;25(13):1677-82. doi: 10.1200/JCO.2006.08.9383. Epub 2007 Apr 2. J Clin Oncol. 2007. PMID: 17404368 Clinical Trial.

2

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, et al. Antman K, et al. J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102. J Clin Oncol. 1992. PMID: 1727912 Clinical Trial.

3

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al. Elias AD, et al. J Clin Oncol. 1991 Feb;9(2):320-7. doi: 10.1200/JCO.1991.9.2.320. J Clin Oncol. 1991. PMID: 1846407 Clinical Trial.

4

Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH. Elias A, et al. J Clin Oncol. 1989 Sep;7(9):1208-16. doi: 10.1200/JCO.1989.7.9.1208. J Clin Oncol. 1989. PMID: 2504890 Clinical Trial.

5

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

Eder JP, Antman K, Peters W, Henner WD, Elias A, Shea T, Schryber S, Andersen J, Come S, Schnipper L, et al. Eder JP, et al. J Clin Oncol. 1986 Nov;4(11):1592-7. doi: 10.1200/JCO.1986.4.11.1592. J Clin Oncol. 1986. PMID: 3534155

6

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

Ayash LJ, Elias A, Wheeler C, Reich E, Schwartz G, Mazanet R, Tepler I, Warren D, Lynch C, Gonin R, et al. Ayash LJ, et al. J Clin Oncol. 1994 Jan;12(1):37-44. doi: 10.1200/JCO.1994.12.1.37. J Clin Oncol. 1994. PMID: 7505807

7

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.

Ayash LJ, Wheeler C, Fairclough D, Schwartz G, Reich E, Warren D, Schnipper L, Antman K, Frei E 3rd, Elias A. Ayash LJ, et al. J Clin Oncol. 1995 Aug;13(8):2043-9. doi: 10.1200/JCO.1995.13.8.2043. J Clin Oncol. 1995. PMID: 7636547 Clinical Trial.

8

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.

Wheeler C, Strawderman M, Ayash L, Churchill WH, Bierer BE, Elias A, Gilliland DG, Antman K, Guinan EC, Eder JP, et al. Wheeler C, et al. J Clin Oncol. 1993 Jun;11(6):1085-91. doi: 10.1200/JCO.1993.11.6.1085. J Clin Oncol. 1993. PMID: 8099120

9

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL, et al. Antman K, et al. J Clin Oncol. 1993 Jul;11(7):1276-85. doi: 10.1200/JCO.1993.11.7.1276. J Clin Oncol. 1993. PMID: 8315425 Clinical Trial.

10

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.

Ayash LJ, Elias A, Schwartz G, Wheeler C, Ibrahim J, Teicher BA, Reich E, Warren D, Lynch C, Richardson P, Schnipper L, Frei E 3rd, Antman K. Ayash LJ, et al. J Clin Oncol. 1996 Nov;14(11):2984-92. doi: 10.1200/JCO.1996.14.11.2984. J Clin Oncol. 1996. PMID: 8918496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page